Abiopharma

🔍 Leonard Michael J (Executive)

Company: Ingredion Inc (INGR)

Report Date: 2026-07-31

Detailed Transactions and Holdings:

• Acquired 34 shares of Phantom Stock (Derivative)
  Date: 2026-07-31 | Code: A | equity_swap_involved: 0 | shares_owned_after: 1,801.48 | transaction_form_type: 4 | Footnotes: F1, F1, F1, F2

Footnotes:

• F1: Represents the aggregate number of shares of phantom stock allocated to the reporting person under the Non-Qualified Deferred Compensation Plan as of the date hereof based on the closing price of a share of the issuer's Common Stock on July 31, 2026. Each phantom stock unit represents the right to receive one share of common stock.
• F2: Includes shares of phantom stock acquired through dividend reinvestment.